Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$798,112
-$119,160 QoQ
Shares Held
2,204
-15.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,850
of 3,140 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Keel Point, LLC holds $22,441,479 across 10 Drug Manufacturers - General names. AMGN ranks #7 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,474 | $6,215,661 | |
| 2 | MRK |
Merck & Co., Inc.
|
36,633 | $4,707,340 | |
| 3 | LLY |
ELI LILLY & Co
|
3,650 | $4,377,919 | |
| 4 | ABBV |
AbbVie Inc.
|
11,997 | $3,018,925 | |
| 5 | NVS |
Novartis AG
|
6,229 | $976,208 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,068 | $892,971 | |
| 7 | AMGN |
Amgen Inc
This page
|
2,204 | $798,112 | |
| 8 | AZN |
Astrazeneca PLC
|
3,042 | $576,824 |
All Filings in AMGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $798,112 | 2,204 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $917,272 | 2,607 | Shares | Sole | 2026-06-01 | |
| 2025-12-31 | $1,188,135 | 3,630 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,023,821 | 3,628 | Shares | Sole | 2025-12-16 | |
| 2025-06-30 | $1,054,017 | 3,775 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $947,112 | 3,040 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $642,477 | 2,465 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $855,467 | 2,655 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $849,864 | 2,720 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $615,268 | 2,164 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $611,466 | 2,123 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $541,820 | 2,016 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $417,841 | 1,882 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $395,019 | 1,634 | Shares | Sole | 2023-04-03 | |
| 2022-12-31 | $440,447 | 1,677 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $332,239 | 1,474 | Shares | Sole | 2022-10-05 | |
| 2022-06-30 | $353,271 | 1,452 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $334,678 | 1,384 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $288,186 | 1,281 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $264,961 | 1,246 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $300,056 | 1,231 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $307,777 | 1,237 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||